These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28652770)

  • 1. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
    Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
    Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study.
    de Ruiter JC; van der Noort V; van Diessen JNA; Smit EF; Damhuis RAM; Hartemink KJ;
    Lung Cancer; 2024 May; 191():107792. PubMed ID: 38621343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Outcome after Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer: A Meta-Analysis.
    Yu XJ; Dai WR; Xu Y
    J Invest Surg; 2017 Aug; ():1-8. PubMed ID: 28829659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy or surgery for stage I-II non-small cell lung cancer treatment?-outcomes of a meta-analysis.
    Zhang Q; Shao L; Tian J; Liu R; Geng Y; Liao Y; Luo H; Ge L; Feng S; Wang X; Yang Z
    Transl Cancer Res; 2019 Aug; 8(4):1381-1394. PubMed ID: 35116881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
    Chang JY; Senan S; Paul MA; Mehran RJ; Louie AV; Balter P; Groen HJ; McRae SE; Widder J; Feng L; van den Borne BE; Munsell MF; Hurkmans C; Berry DA; van Werkhoven E; Kresl JJ; Dingemans AM; Dawood O; Haasbeek CJ; Carpenter LS; De Jaeger K; Komaki R; Slotman BJ; Smit EF; Roth JA
    Lancet Oncol; 2015 Jun; 16(6):630-7. PubMed ID: 25981812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.
    Chiang A; Thibault I; Warner A; Rodrigues G; Palma D; Soliman H; Jain S; Poon I; Cheung P
    Radiother Oncol; 2016 Mar; 118(3):478-84. PubMed ID: 26795773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.
    Rusthoven CG; Kavanagh BD; Karam SD
    Ann Transl Med; 2015 Jul; 3(11):149. PubMed ID: 26244136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
    Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review.
    Wang S; Wang X; Zhou Q; Xu Y; Xia W; Xu W; Ma Z; Qiu M; You R; Xu L; Yin R
    Thorac Cancer; 2018 Mar; 9(3):337-347. PubMed ID: 29322682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
    van den Berg LL; Klinkenberg TJ; Groen HJM; Widder J
    J Thorac Oncol; 2015 May; 10(5):826-831. PubMed ID: 25629639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
    Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
    J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis.
    Safavi AH; Mak DY; Boldt RG; Chen H; Louie AV
    Lung Cancer; 2021 Oct; 160():179-186. PubMed ID: 34330566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Viani GA; Gouveia AG; Louie AV; Arcidiacono F; Simone CB; Tsakiridis T; Carolina Hamamura A; Anselmo P; Moraes FY
    Radiother Oncol; 2024 Dec; 201():110439. PubMed ID: 39032835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
    de Ruiter JC; van Diessen JNA; Smit EF; van der Noort V; Damhuis RAM; Hartemink KJ;
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35348664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic or Conventional Radiation for Early-Stage Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Mutsaers A; Zhang TW; Louie A; Rodrigues G; Palma D; Qu M
    Cureus; 2023 Apr; 15(4):e38198. PubMed ID: 37252503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy.
    Milano MT; Kong FS; Movsas B
    Transl Lung Cancer Res; 2019 Feb; 8(1):78-87. PubMed ID: 30788237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis.
    Hegi F; D'Souza M; Azzi M; De Ruysscher D
    Clin Lung Cancer; 2018 May; 19(3):199-212. PubMed ID: 29370978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.